Use of recombinant factor VIII Advate in paediatric patients

Please copy the URL and add it into your RSS Feed Reader.

Hamostaseologie 2009; 29(S 01): S47-S49
DOI: 10.1055/s-0037-1617211

Communication

Schattauer GmbH

First steps in the Czech Republic

Authors

V. Komrska

¹Dept. of Paediatric Haematology and Oncology of the University Hospital Motol in Praha
E. Pindurová

¹Dept. of Paediatric Haematology and Oncology of the University Hospital Motol in Praha
S. Krekeler

¹Dept. of Paediatric Haematology and Oncology of the University Hospital Motol in Praha
B. Blažek

²Children Dept. of the University Hospital in Ostrava
H. Ptoszková

²Children Dept. of the University Hospital in Ostrava
Z. Cerná

³Children Dept. of the University Hospital in Plzen
D. Pospíšilová

⁴Children Dept. of the University Hospital in Olomouc
O. Zapletal

⁵Dept. of Clinical Haematology of University Hospital in Brno

Publication Date:
30 December 2017 (online)